Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia.

Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia. J Clin Oncol. 2010 Aug 10; 28(23):3724-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.